Personen

TOP 5 Publikationen:

1. de Haan L, Sutterland AL, Schotborgh JV, Schirmbeck F, de Haan L. Association of Toxoplasma gondii Seropositivity With Cognitive Function in Healthy People: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2021 78(10):1103-1112.
2. Myin-Germeys I, van Aubel E, Vaessen T, Steinhart H, Klippel A, Lafit G, Viechtbauer W, Batink T, van Winkel R, van der Gaag M, van Amelsvoort T, Marcelis M, Schirmbeck F, de Haan L, Reininghaus U. Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial.Psychother Psychosom. 2022 91(6):411-423. Epub 2022 Mar 18.
3. Lin BD, Pinzón-Espinosa J, Blouzard E, van der Horst MZ, Okhuijsen-Pfeifer C, van Eijk KR, Gülöksüz S, Peyrot WJ, Luykx JJ, Genetic Risk and Outcome of Psychosis (GROUP) and Clozapine International Consortium (CLOZIN) Investigators , ..... ....., Schirmbeck F, ..... ...... Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.JAMA Psychiatry. 2023 80(2):181-185.
4. Reininghaus U, Reinhold AS, Priebe S, Rauschenberg C, Fleck L, Schick A, Schirmbeck F, Myin-Germeys I, Morgan C, Hartmann JA. Toward Equitable Interventions in Public Mental Health: A Review.JAMA Psychiatry. 2024 81(12):1270-1275. Epub 2024 Oct 16.
5. Vermeulen J, Schirmbeck F, Blankers M, van Tricht M, van den Brink W, de Haan L, Genetic Risk and Outcome of Psychosis (GROUP) investigators . Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study.Lancet Psychiatry. 2019 6(1):25-34.